These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 34764984)

  • 61. Integrative Multi-Omics Analysis of Identified NUF2 as a Candidate Oncogene Correlates With Poor Prognosis and Immune Infiltration in Non-Small Cell Lung Cancer.
    Chen M; Li S; Liang Y; Zhang Y; Luo D; Wang W
    Front Oncol; 2021; 11():656509. PubMed ID: 34178642
    [TBL] [Abstract][Full Text] [Related]  

  • 62. The correlation of WDR76 expression with survival outcomes and immune infiltrates in lung adenocarcinoma.
    Fang L; Yu G; Yu W; Chen G; Ye B
    PeerJ; 2021; 9():e12277. PubMed ID: 34707943
    [TBL] [Abstract][Full Text] [Related]  

  • 63. CASC5 is a potential tumour driving gene in lung adenocarcinoma.
    Cui Y; Zhang C; Ma S; Guo W; Cao W; Guan F
    Cell Biochem Funct; 2020 Aug; 38(6):733-742. PubMed ID: 32283571
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Identification of GPD1L as a Potential Prognosis Biomarker and Associated with Immune Infiltrates in Lung Adenocarcinoma.
    Fan Z; Wu S; Sang H; Li Q; Cheng S; Zhu H
    Mediators Inflamm; 2023; 2023():9162249. PubMed ID: 37035759
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Development and validation of an immune-related prognostic signature in lung adenocarcinoma.
    Sun S; Guo W; Wang Z; Wang X; Zhang G; Zhang H; Li R; Gao Y; Qiu B; Tan F; Gao Y; Xue Q; Gao S; He J
    Cancer Med; 2020 Aug; 9(16):5960-5975. PubMed ID: 32592319
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Overexpression of Family with Sequence Similarity 83, Member A (FAM83A) Predicts Poor Clinical Outcomes in Lung Adenocarcinoma.
    Zhang JT; Lin YC; Xiao BF; Yu BT
    Med Sci Monit; 2019 Jun; 25():4264-4272. PubMed ID: 31175804
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Comprehensive Analysis of NPSR1-AS1 as a Novel Diagnostic and Prognostic Biomarker Involved in Immune Infiltrates in Lung Adenocarcinoma.
    Zhang H; Yuan J; Xiang Y; Liu Y
    J Oncol; 2022; 2022():2099327. PubMed ID: 36284635
    [TBL] [Abstract][Full Text] [Related]  

  • 68. CKS2 Overexpression Correlates with Prognosis and Immune Cell Infiltration in Lung Adenocarcinoma: A Comprehensive Study based on Bioinformatics and Experiments.
    Wang Z; Zhang M; Wu Y; Yu Y; Zheng Q; Li J
    J Cancer; 2021; 12(23):6964-6978. PubMed ID: 34729099
    [No Abstract]   [Full Text] [Related]  

  • 69. Low expression of RGL4 is associated with a poor prognosis and immune infiltration in lung adenocarcinoma patients.
    Sun Y; Zhang Y; Ren S; Li X; Yang P; Zhu J; Lin L; Wang Z; Jia Y
    Int Immunopharmacol; 2020 Jun; 83():106454. PubMed ID: 32259700
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Prognostic Value of UBE2T and Its Correlation with Immune Infiltrates in Lung Adenocarcinoma.
    Xu F; Xiong N; Yuan Y; Liu J
    J Oncol; 2022; 2022():5244820. PubMed ID: 36245987
    [TBL] [Abstract][Full Text] [Related]  

  • 71. DNASE1L3 as a Novel Diagnostic and Prognostic Biomarker for Lung Adenocarcinoma Based on Data Mining.
    Chen J; Ding J; Huang W; Sun L; Chen J; Liu Y; Zhan Q; Gao G; He X; Qiu G; Long P; Wei L; Lu Z; Sun Y
    Front Genet; 2021; 12():699242. PubMed ID: 34868195
    [TBL] [Abstract][Full Text] [Related]  

  • 72. The downregulation of fibrinogen-like protein 1 inhibits the proliferation of lung adenocarcinoma via regulating
    Tang XY; Xiong YL; Shi AP; Sun Y; Han Q; Lv Y; Shi XG; Frattini M; Malhotra J; Zheng KF; Liu YJ; Jiang T; Ma N; Zhao JB
    Transl Lung Cancer Res; 2022 Mar; 11(3):404-419. PubMed ID: 35399566
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Identification and Validation of Immune-Related LncRNA Prognostic Signature for Lung Adenocarcinoma.
    Wu G; Wang Q; Zhu T; Fu L; Li Z; Wu Y; Zhang C
    Front Genet; 2021; 12():681277. PubMed ID: 34306024
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Aberrant S100A16 expression might be an independent prognostic indicator of unfavorable survival in non-small cell lung adenocarcinoma.
    Chen D; Luo L; Liang C
    PLoS One; 2018; 13(5):e0197402. PubMed ID: 29746588
    [TBL] [Abstract][Full Text] [Related]  

  • 75. MECOM/PRDM3 and PRDM16 Serve as Prognostic-Related Biomarkers and Are Correlated With Immune Cell Infiltration in Lung Adenocarcinoma.
    Li M; Ren H; Zhang Y; Liu N; Fan M; Wang K; Yang T; Chen M; Shi P
    Front Oncol; 2022; 12():772686. PubMed ID: 35174083
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Identification of cancer stem cell-related biomarkers in lung adenocarcinoma by stemness index and weighted correlation network analysis.
    Zhao M; Chen Z; Zheng Y; Liang J; Hu Z; Bian Y; Jiang T; Li M; Zhan C; Feng M; Wang Q
    J Cancer Res Clin Oncol; 2020 Jun; 146(6):1463-1472. PubMed ID: 32221746
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Identification and validation of smoking-related genes in lung adenocarcinoma using an in vitro carcinogenesis model and bioinformatics analysis.
    Wang J; Chen T; Yu X; OUYang N; Tan L; Jia B; Tong J; Li J
    J Transl Med; 2020 Aug; 18(1):313. PubMed ID: 32795291
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Genetic and microenvironmental differences in non-smoking lung adenocarcinoma patients compared with smoking patients.
    Sui Q; Liang J; Hu Z; Chen Z; Bi G; Huang Y; Li M; Zhan C; Lin Z; Wang Q
    Transl Lung Cancer Res; 2020 Aug; 9(4):1407-1421. PubMed ID: 32953513
    [TBL] [Abstract][Full Text] [Related]  

  • 79. GPI Is a Prognostic Biomarker and Correlates With Immune Infiltrates in Lung Adenocarcinoma.
    Han J; Deng X; Sun R; Luo M; Liang M; Gu B; Zhang T; Peng Z; Lu Y; Tian C; Yan Y; Luo Z
    Front Oncol; 2021; 11():752642. PubMed ID: 34912709
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Heparin binding epidermal growth factor-like growth factor is a prognostic marker correlated with levels of macrophages infiltrated in lung adenocarcinoma.
    Van Hiep N; Sun WL; Feng PH; Lin CW; Chen KY; Luo CS; Dung LN; Van Quyet H; Wu SM; Lee KY
    Front Oncol; 2022; 12():963896. PubMed ID: 36439487
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.